by GCP Central | Dec 13, 2021 | GCP Central News
On November 1, 2021, the new Local Feasibility Procedure and the use of the Research Institute Suitability Statement (VGO) will be in place. This is mandatory for drug research. We spoke with Sanofi’s Thera Max-Mos, Head Clinical Study Unit ai, NL, to...
by GCP Central | Apr 20, 2021 | GCP Central News
We’re proud to announce that Marieke Meulemans will present “ European Clinical Trial Regulation (ECTR) and Medical Device Regulation (MDR)” on April 21st, 2021, with co-panelists Rianne Tooten and Isabelle van der Haegen. This session will be held between...
by GCP Central | Mar 15, 2021 | GCP Central News, GCP Central Products
With the constant increase of our e-learner base, we think of ways to accommodate your different learning and compliance needs. This is why we recently launched our new Refresher ICH GCP Course for Clinical Drug Trials in Germany. Our Refresher ICH GCP Course is...
by GCP Central | Jan 26, 2021 | GCP Central News, GCP Central Products
With the start of the new year, we launched our new Good Manufacturing Practice (GMP) online course that covers the legal requirements and best practices for quality oversight on external manufacturing. The GMP quality oversight course for European drug products is a...
by GCP Central | Dec 23, 2020 | myGCP Software Release
In our ongoing commitment to high-quality GCP training, as well as providing you with the latest updates available, myGCP will undergo a software update on January 15, 2021. Read on to discover what’s new in myGCP version 2.11 User Friendly We’ve...
by GCP Central | Dec 7, 2020 | GCP Central News, GCP Central Products
Announcing the latest addition to the GCP Central online course offerings: Expert ICH GCP Course for Sponsors in International Clinical Trials. Our newest course is based on the Sponsors’ responsibilities, as documented in Section 5 of ICH GCP E6(R2). Explicitly...
